A Comprehensive Review of Liver Allograft Fibrosis and Steatosis: From Cause to Diagnosis
Despite advances in posttransplant care, long-term outcomes for liver transplant recipients remain unchanged. Approximately 25% of recipients will advance to graft cirrhosis and require retransplantation. Graft fibrosis progresses in the context of de novo or recurrent disease. Recurrent hepatitis C...
Main Authors: | Madhumitha Rabindranath, HBSc, Rita Zaya, MD, Khairunnadiya Prayitno, PhD, Ani Orchanian-Cheff, MISt, Keyur Patel, MD, PhD, Elmar Jaeckel, MD, Mamatha Bhat, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2023-11-01
|
Series: | Transplantation Direct |
Online Access: | http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001547 |
Similar Items
-
Magnetic Resonance Imaging for Evaluation of Interstitial Fibrosis in Kidney Allografts
by: Andrea Beck-Tölly, MD, et al.
Published: (2020-08-01) -
A deep learning framework for personalised dynamic diagnosis of graft fibrosis after liver transplantation: a retrospective, single Canadian centre, longitudinal study
by: Amirhossein Azhie, MD, et al.
Published: (2023-07-01) -
Renal Autotransplantation and Extracorporeal Nephron-Sparing Surgery for De Novo Renal Cell Carcinoma in a Kidney Allograft
by: Shinichiro Ono, MD, PhD, et al.
Published: (2017-08-01) -
Early Allograft Dysfunction After Liver Transplantation With Donation After Circulatory Death and Brain Death Grafts: Does the Donor Type Matter?
by: Laura Ioana Mazilescu, MD, et al.
Published: (2021-08-01) -
Time-dependent blood eosinophilia count increases the risk of kidney allograft rejection
by: Luc Colas, MD, PhD, et al.
Published: (2021-11-01)